Licensed in the EU as Monotherapy to Treat Adult Patients with Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas*
* The benefit of pixantrone treatment has not been established in patients when used as fifth line or greater chemotherapy in patients who are refractory to last therapy.
Privacy Policy
Terms and Conditions
Contact
©2013 All rights reserved.May 2013 PIX-GB-09-2012-0013
This site intended for EU residents only.